Načítá se...

Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

Gangliosides, such as GM2, GD2, GD3, and 9-O-acetyl GD3, are receiving attention as targets for antibody-based and vaccine-based therapies of melanoma. GM2 appears to be a particularly immunogenic ganglioside in humans, as indicated by the presence of naturally occurring IgM anti-GM2 antibodies in a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kitamura, K, Livingston, P O, Fortunato, S R, Stockert, E, Helling, F, Ritter, G, Oettgen, H F, Old, L J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1995
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC42307/
https://ncbi.nlm.nih.gov/pubmed/7708728
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!